CLINICAL_TRIALS trial_result · 2020-06-26

Clinical Trial Update: A Study of LY2623091 in Participants With High Blood Pressure [Phase 2]

Phase 2 clinical trial update for LY2623091 in participants with high blood pressure (primary hypertension) has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Primary Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2020-06-26